CaMKII, endocannabinoids, synaptic plasticity and motor function

CaMKII、内源性大麻素、突触可塑性和运动功能

基本信息

  • 批准号:
    8885927
  • 负责人:
  • 金额:
    $ 38.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-01 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The striatum plays a key role in motor activity/coordination and goal-directed, habitual learning. Normal striatal drive of motor activity requires precisely balanced opposing outputs from two types of striatal medium spiny neurons (MSNs) that express D1- and D2-dopamine(DA) receptors. A complex signaling cross-talk between glutamate and DA in D1- and D2-MSNs involves "on demand" Ca2+-dependent endocannabinoid (eCB) synthesis. Thus, DA, glutamate and eCBs collaborate to balance short- and long-term control of the two striatal output pathways by engaging distinct signaling mechanisms in the two MSN subtypes. Disruption of these mechanisms can induce motor deficits (e.g., Parkinson's Disease) or other abnormal striatal-based behaviors. Ca2+/calmodulin-dependent protein kinase II (CaMKII) has diverse bidirectional roles controlling excitatory synapses in hippocampus, cortex and cerebellum. While CaMKII is expressed in both striatal MSN subtypes, suggesting that it regulates excitatory inputs to striatal MSNs and motor activity, the precise functions of striatal CaMKII are poorly understood. Our analyses of knockin mutant mice with the Thr286 autophosphorylation site in CaMKIIα replaced by Ala (T286A-KI mice) revealed specific roles for CaMKII in long- and short term eCB- dependent control of excitatory inputs to D1- and D2-MSNs. We also found that CaMKIIα associates with and phosphorylates diacylglycerol lipase α (DGLα), the rate-limiting enzyme for Ca2+-dependent synthesis of the most abundant brain eCB, 2-arachidonyl glycerol (2-AG). In addition, baseline hyperactivity of T286A-KI mice can be rescued by inhibiting 2-AG breakdown. These initial findings strongly support a novel hypothesis that CaMKII is a critical link between postsynaptic Ca2+ and the initiation of 2-AG signaling that controls striatal synapses and striatal based-behaviors. We also created novel transgenic eAC3I mice that selectively express a short CaMKII inhibitor peptide fused to eGFP in striatal MSNs. Three specific aims will exploit unique features of T286A-KI and eAC3I mice to test specific hypotheses about the roles of striatal CaMKII autophosphorylation and activity. 1. Test the hypothesis that Ca2+-dependent 2-AG synthesis is modulated by CaMKII. We will identify sites of phosphorylation and CaMKII-binding domains in DGLα. DGLα phosphorylation, DGLα activity and 2-AG synthesis will be investigated in heterologous cells and in striatal slices from WT, T286A-KI and eAC3I mice. 2. Test the hypothesis that CaMKII modulates eCB-dependent synaptic regulation in striatal MSNs. Short and long-term roles of CaMKII will be determined by comparing the properties of excitatory synaptic inputs to D1- and D2-MSNs in striatal slices from WT, T286A-KI and eAC3I mice, and by using CaMKII inhibitor peptides. 3. Test the hypothesis that CaMKII modulates eCB-dependent motor activity. We will evaluate motor activity and coordination under basal conditions and following pharmacological modulation of 2-AG metabolism in WT, T286A-KI and eAC3I mice.
描述(申请人提供):纹状体在运动活动/协调和目标导向的习惯性学习中起着关键作用。运动活动的正常纹状体驱动 需要两种纹状体中棘神经元(MSN)精确平衡的相反输出,这些神经元表达D1-和D2-多巴胺(DA)受体。在D_1和D_2-MSN中,谷氨酸和DA之间复杂的信号串扰涉及“按需”依赖的内源性大麻素(ECB)的合成。因此,DA、谷氨酸和ECB通过在两个MSN亚型中使用不同的信号机制来协作平衡对两个纹状体输出通路的短期和长期控制。这些机制的破坏会导致运动障碍(如帕金森氏病)或其他基于纹状体的异常行为。钙/钙调蛋白依赖的蛋白激酶II(CaMKII)在海马区、大脑皮层和小脑中对兴奋性突触具有不同的双向调控作用。虽然CaMKII在两种纹状体MSN亚型中都有表达,这表明它调节纹状体MSN的兴奋性输入和运动活动,但纹状体CaMKII的确切功能尚不清楚。我们对CaMKIIα中Thr286自动磷酸化位点被ALA取代的敲门突变小鼠(T286A-Ki小鼠)的分析揭示了CaMKII在依赖于欧洲央行的长期和短期控制兴奋输入到D1-和D2-MSN中的特定作用。我们还发现,CaMKIIα与二酰基甘油脂肪酶α(Dglα)结合并磷酸化,Dgl Dgl是依赖钙离子合成脑内最丰富的ECB-2-花生四烯基甘油(2-AG)的限速酶。此外,T286A-Ki小鼠的基线多动可通过抑制2-AG的降解来挽救。这些初步发现有力地支持了一种新的假说,即CaMKII是突触后钙离子和控制纹状体突触和基于纹状体的行为的2-AG信号启动之间的关键联系。我们还创造了新的转基因eAC3I小鼠,在纹状体MSN中选择性地表达与EGFP融合的CaMKII抑制短肽。三个特定的目标将利用T286A-Ki和eAC3I小鼠的独特特征来测试关于纹状体CaMKII自动磷酸化和活性的特定假设。1.验证钙依赖的2-AG合成受CaMKII调控的假说。我们将确定Dglα中的磷酸化和CaMKII结合域的位置。将在异种细胞和WT、T286A-KI和eAC3I小鼠的纹状体切片中研究Dglα的磷酸化、Dglα的活性和2-AG的合成。2.验证CaMKII调节纹状体MSN中ECB依赖的突触调节的假设。CaMKII的短期和长期作用将通过比较WT、T286A-KI和eAC3I小鼠纹状体切片中兴奋性突触输入到D1和D2-MSN的特性以及使用CaMKII抑制肽来确定。3.验证CaMKII调节ECB依赖的运动活动的假设。我们将评估WT、T286A-KI和eAC3I小鼠在基础条件下的运动活性和协调性,以及药物对2-AG代谢的调节。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROGER J COLBRAN其他文献

ROGER J COLBRAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROGER J COLBRAN', 18)}}的其他基金

Molecular Neuropharmacology and Signaling of Histone H2A.Z
组蛋白 H2A.Z 的分子神经药理学和信号转导
  • 批准号:
    9626431
  • 财政年份:
    2017
  • 资助金额:
    $ 38.22万
  • 项目类别:
Molecular Neuropharmacology and Signaling of Histone H2A.Z
组蛋白 H2A.Z 的分子神经药理学和信号转导
  • 批准号:
    9480880
  • 财政年份:
    2017
  • 资助金额:
    $ 38.22万
  • 项目类别:
Molecular Neuropharmacology and Signaling of Histone H2A.Z
组蛋白 H2A.Z 的分子神经药理学和信号转导
  • 批准号:
    10115117
  • 财政年份:
    2017
  • 资助金额:
    $ 38.22万
  • 项目类别:
Postdoctoral Program in Functional Neurogenomics
功能神经基因组学博士后项目
  • 批准号:
    9386221
  • 财政年份:
    2016
  • 资助金额:
    $ 38.22万
  • 项目类别:
CaMKII, endocannabinoids, synaptic plasticity and motor function
CaMKII、内源性大麻素、突触可塑性和运动功能
  • 批准号:
    8536971
  • 财政年份:
    2012
  • 资助金额:
    $ 38.22万
  • 项目类别:
CaMKII, endocannabinoids, synaptic plasticity and motor function
CaMKII、内源性大麻素、突触可塑性和运动功能
  • 批准号:
    8697154
  • 财政年份:
    2012
  • 资助金额:
    $ 38.22万
  • 项目类别:
CaMKII, endocannabinoids, synaptic plasticity and motor function
CaMKII、内源性大麻素、突触可塑性和运动功能
  • 批准号:
    9102281
  • 财政年份:
    2012
  • 资助金额:
    $ 38.22万
  • 项目类别:
CaMKII, endocannabinoids, synaptic plasticity and motor function
CaMKII、内源性大麻素、突触可塑性和运动功能
  • 批准号:
    8438247
  • 财政年份:
    2012
  • 资助金额:
    $ 38.22万
  • 项目类别:
Postdoctoral Program in Functional Neurogenomics
功能神经基因组学博士后项目
  • 批准号:
    9925810
  • 财政年份:
    2002
  • 资助金额:
    $ 38.22万
  • 项目类别:
Postdoctoral Program in Functional Neurogenomics
功能神经基因组学博士后项目
  • 批准号:
    9096901
  • 财政年份:
    2002
  • 资助金额:
    $ 38.22万
  • 项目类别:

相似海外基金

How exercise improves ataxia in SCA6
运动如何改善 SCA6 的共济失调
  • 批准号:
    479005
  • 财政年份:
    2023
  • 资助金额:
    $ 38.22万
  • 项目类别:
    Operating Grants
Role of POU4F1 in a Novel Form of Ataxia
POU4F1 在新型共济失调中的作用
  • 批准号:
    10741382
  • 财政年份:
    2023
  • 资助金额:
    $ 38.22万
  • 项目类别:
Exploratoin of Nrf2 activators that potentiate chaperone-mediated autophagy and are useful for the treatment of spinocrebellar ataxia
探索增强伴侣介导的自噬并可用于治疗脊髓小脑共济失调的 Nrf2 激活剂
  • 批准号:
    23K06161
  • 财政年份:
    2023
  • 资助金额:
    $ 38.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Defining the role of Tox3 in congenital cerebellar hypoplasia and ataxia
定义 Tox3 在先天性小脑发育不全和共济失调中的作用
  • 批准号:
    10799992
  • 财政年份:
    2023
  • 资助金额:
    $ 38.22万
  • 项目类别:
Genome-wide dysregulation of R-loops in Ataxia Telangiectasia neurological pathogenesis
共济失调毛细血管扩张症神经发病机制中 R 环的全基因组失调
  • 批准号:
    10607414
  • 财政年份:
    2023
  • 资助金额:
    $ 38.22万
  • 项目类别:
Identifying the molecular mechanisms of GEMIN5 mutations in a novel cerebellar ataxia syndrome
鉴定新型小脑共济失调综合征中 GEMIN5 突变的分子机制
  • 批准号:
    10753403
  • 财政年份:
    2023
  • 资助金额:
    $ 38.22万
  • 项目类别:
Project 2: Therapeutic Gene Editing for Friedreich's Ataxia
项目 2:弗里德赖希共济失调的治疗性基因编辑
  • 批准号:
    10668768
  • 财政年份:
    2023
  • 资助金额:
    $ 38.22万
  • 项目类别:
Molecular Pathogenesis of spinocerebellar ataxia type 12
12 型脊髓小脑共济失调的分子发病机制
  • 批准号:
    10579736
  • 财政年份:
    2023
  • 资助金额:
    $ 38.22万
  • 项目类别:
The Impact of Vitamin D on mTOR Signaling, Seizures, and Motor Behavior in a Mouse Model of Hyperactive mTOR Induced Epilepsy and Ataxia
维生素 D 对 mTOR 过度活跃诱发癫痫和共济失调小鼠模型中 mTOR 信号传导、癫痫发作和运动行为的影响
  • 批准号:
    10754319
  • 财政年份:
    2023
  • 资助金额:
    $ 38.22万
  • 项目类别:
Pathological Mechanisms of Immune-Mediated Cerebellar Ataxia with Associated Sez6L2 Autoantibodies
免疫介导的小脑共济失调与相关 Sez6L2 自身抗体的病理机制
  • 批准号:
    10740682
  • 财政年份:
    2023
  • 资助金额:
    $ 38.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了